IndiaTickerLatest filing: Ajanta Pharma Ltd - 532331 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript
ObservedCompany dossier
Ajanta Pharma
NSE:AJANTPHARM · ISIN INE031B01049
- Close
- Unavailable Date unavailable
- Daily change
- N/A Exchange close
- Evidence state
- Building 0/0 checks
Ajanta Pharma
Overview
Evidence state
Coverage in progressCompany record at a glance
Latest reported period: 31 Dec 2024 · revenue ₹1,146.1 Cr · PAT ₹232.9 Cr.
Exchange XBRLLatest ownership: promoter group 63.48% and public 36.52% as of 30 Jun 2026.
Exchange XBRLMaterial events
Open timeline →What changed recently
Observed
Source filing Ajanta Pharma Ltd - 532331 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript
BSE · conference call
Observed
Source filing Ajanta Pharma Ltd - 532331 - Announcement under Regulation 30 (LODR)-Newspaper Publication
BSE · financial results
Observed
Source filing Copy of Newspaper Publication - Ajanta Pharma Limited
NSE · exchange filing
Observed
Source filing Ajanta Pharma Ltd - 532331 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
BSE · conference call
Reported financials
Full financials →31 Dec 2024
- Revenue from operations
- ₹1,146.1 Cr
- Profit after tax
- ₹232.9 Cr
- EPS
- ₹18.60
Observed NSE structured filing · Consolidated
Ownership
Full shareholding →30 Jun 2026
- Promoter group
- 63.48%
- Public
- 36.52%
- Employee trust
- 0.00%
Observed NSE shareholding XBRL